 Sarat Vatsavayai, PhD
| Title(s) | UCSF Weill Institute for Neurosciences |
|---|
|
|---|
|
 Bibliographic
-
Sampognaro PJ, Vatsavayai SC, Cosme CG, Hwang JL, Nolan A, Huang EJ, Seeley WW, De May MG. C9orf72-specific phenomena associated with frontotemporal dementia and gastrointestinal symptoms in the absence of TDP-43 aggregation. Acta Neuropathol. 2019 Dec; 138(6):1093-1097. PMID: 31624869.
-
Vatsavayai SC, Nana AL, Yokoyama JS, Seeley WW. C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies. Acta Neuropathol. 2019 01; 137(1):1-26. PMID: 30368547.
-
Celona B, Dollen JV, Vatsavayai SC, Kashima R, Johnson JR, Tang AA, Hata A, Miller BL, Huang EJ, Krogan NJ, Seeley WW, Black BL. Suppression of C9orf72 RNA repeat-induced neurotoxicity by the ALS-associated RNA-binding protein Zfp106. Elife. 2017 01 10; 6. PMID: 28072389.
-
Eun-Joo Kim, Sarat Vatsavayai, William W. Seeley. Neuropathology of dementia. The Behavioral Neurology of Dementia. 2017 Jan 1; 94-122.
-
Vatsavayai SC, Yoon SJ, Gardner RC, Gendron TF, Vargas JN, Trujillo A, Pribadi M, Phillips JJ, Gaus SE, Hixson JD, Garcia PA, Rabinovici GD, Coppola G, Geschwind DH, Petrucelli L, Miller BL, Seeley WW. Timing and significance of pathological features in C9orf72 expansion-associated frontotemporal dementia. Brain. 2016 12; 139(Pt 12):3202-3216. PMID: 27797809.
-
Dallérac GM, Levasseur G, Vatsavayai SC, Milnerwood AJ, Cummings DM, Kraev I, Huetz C, Evans KA, Walters SW, Rezaie P, Cho Y, Hirst MC, Murphy KP. Dysfunctional Dopaminergic Neurones in Mouse Models of Huntington's Disease: A Role for SK3 Channels. Neurodegener Dis. 2015; 15(2):93-108. PMID: 25871323.
-
KPSJ Murphy, GM Dallerac, AJ Milnerwood, DM Cummings, SC Vatsavayai, A Stramek, KA Evans, SW Walters, MC Hirst. B24 Dysfunctional dopaminergic neurones and biphasic activity-dependent dopamine release in mouse models of Huntington's disease. Journal of Neurology Neurosurgery & Psychiatry. 2012 Sep 1; 83(Suppl 1):a13.
-
M Hirst, S Vatsavayai, G Dallerac, A Milnerwood, D Cummings, P Rezaie, K Evans, A Stramek, S Walters, K Murphy. B05 CAG profiling in R6/1 89Q indicates early and progressive expansion in critical neuronal populations and expansion and changes in surrounding glial cell populations. Journal of Neurology Neurosurgery & Psychiatry. 2012 Sep 1; 83(Suppl 1):a7.
-
Dallérac GM, Vatsavayai SC, Cummings DM, Milnerwood AJ, Peddie CJ, Evans KA, Walters SW, Rezaie P, Hirst MC, Murphy KP. Impaired long-term potentiation in the prefrontal cortex of Huntington's disease mouse models: rescue by D1 dopamine receptor activation. Neurodegener Dis. 2011; 8(4):230-9. PMID: 21282937.
-
Cummings DM, Milnerwood AJ, Dallérac GM, Vatsavayai SC, Hirst MC, Murphy KP. Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease. Brain Res Bull. 2007 Apr 30; 72(2-3):103-7. PMID: 17352933.
-
Vatsavayai SC, Dallérac GM, Milnerwood AJ, Cummings DM, Rezaie P, Murphy KP, Hirst MC. Progressive CAG expansion in the brain of a novel R6/1-89Q mouse model of Huntington's disease with delayed phenotypic onset. Brain Res Bull. 2007 Apr 30; 72(2-3):98-102. PMID: 17352932.
-
Cummings DM, Milnerwood AJ, Dallérac GM, Waights V, Brown JY, Vatsavayai SC, Hirst MC, Murphy KP. Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease. Hum Mol Genet. 2006 Oct 01; 15(19):2856-68. PMID: 16905556.
-
Milnerwood AJ, Cummings DM, Dallérac GM, Brown JY, Vatsavayai SC, Hirst MC, Rezaie P, Murphy KP. Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease. Hum Mol Genet. 2006 May 15; 15(10):1690-703. PMID: 16600988.
|
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|